SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Auro Laboratories - Quaterly Results

25 May 2024 Evaluate
A decrease in the sales to Rs. 120.63 millions was observed for the quarter ended March 2024. The sales stood at Rs. 135.25 millions during the similar quarter previous year.Net Profit recorded in the quarter ended March 2024 rise to 30.12% to Rs. 23.20  millions  compared to R. 17.83 millions in corresponding previous quarter.The Operating Profit of the company witnessed a decrease to 28.08 millions from 29.71 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 120.63 135.25 -10.81 536.35 528.94 1.40 536.35 528.94 1.40
Other Income 3.99 6.19 -35.54 15.04 9.41 59.83 15.04 9.41 59.83
PBIDT 28.08 29.71 -5.49 121.74 53.34 128.23 121.74 53.34 128.23
Interest -3.25 1.34 -342.54 7.36 8.14 -9.58 7.36 8.14 -9.58
PBDT 31.33 28.37 10.43 114.38 45.20 153.05 114.38 45.20 153.05
Depreciation 2.82 3.04 -7.24 10.92 10.74 1.68 10.92 10.74 1.68
PBT 28.51 25.33 12.55 103.46 34.46 200.23 103.46 34.46 200.23
TAX 5.31 7.50 -29.20 25.54 10.04 154.38 25.54 10.04 154.38
Deferred Tax -1.87 0.03 -6333.33 -1.87 0.03 -6333.33 -1.87 0.03 -6333.33
PAT 23.20 17.83 30.12 77.92 24.42 219.08 77.92 24.42 219.08
Equity 62.32 62.32 0.00 62.32 62.32 0.00 62.32 62.32 0.00
PBIDTM(%) 23.28 21.97 5.97 22.70 10.08 125.08 22.70 10.08 125.08

Auro Laboratories Share Price

274.55 4.85 (1.80%)
11-May-2026 15:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.30
Dr. Reddys Lab 1280.30
Cipla 1307.25
Zydus Lifesciences 955.30
Lupin 2261.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×